Relizen reviews report both relief and disappointment, but the evidence is limited: one small trial found a benefit, while pooled controlled results were not statistically significant. The Menopause Society does not recommend pollen extract for hot flashes. A time-limited try is a personal choice after a safety discussion—not a substitute for better-supported care.
When your sleep is already broken, being told to "give it three months" can feel like a lot to ask. So here is everything worth knowing before you spend that time and money.
Relizen may be worth trying if you:
- Have mild to moderate hot flashes or night sweats
- Want to avoid hormones, or can't take them (with your doctor's okay)
- Can wait two to three months to judge it
- Are comfortable with $33 to $63 per 30-day supply, depending on the plan, and the larger upfront payment on prepaid plans; opened boxes are not returnable under the standard policy
Look at other options first if you:
- Have severe hot flashes that wreck your sleep or your workday
- Need relief within weeks, not months
- Already took Relizen every day for three months without enough change
- Want something your insurance can help pay for
- Mostly struggle with vaginal dryness, mood or weight (Relizen is not an established treatment for those concerns)
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
What we actually verified · Last verified October 2026
We read, on October 16, 2026: Bonafide's Relizen product page, label images, selected customer reviews, subscription and return terms, and Thermella page; the Amazon listing; The Menopause Society's guidance; accessible original study abstracts and the full Bounous study; current drug labeling; and the care providers' relevant offer and policy pages.
We confirmed: Listed prices and payment-plan wording; a 60-tablet bottle and 320 mg blend per two-tablet serving; the seller's once-daily directions; the unopened-product return rules and five-business-day cancellation cutoff; a premenstrual syndrome (PMS)-versus-menopause mismatch in the cited trials; that Bonafide attributes its 75% and 70% figures to a customer survey; and The Menopause Society's not-recommended assessment.
We did not: buy, take or test Relizen, or receive care from any provider named here. This is a documentation and evidence review, not a personal trial.
We could not confirm: Two cited studies' full methods, the customer survey's full methods, Bonafide's current aggregate review widget, or a complete patient-specific Gala quote covering the exact medicine and any required tests. No checkout purchase or service test was performed.
On this page: Buyer reviews · What's in it · Does it work · Claims checked · How long · Side effects · Cost · Who should try it · Alternatives · When to see a clinician · If it didn't work · 90-day worksheet · How we reviewed · FAQ
Relizen reviews: what do buyers actually say?
Relizen has positive seller-published stories and mixed reader experiences elsewhere. The Amazon listing showed 4.0 stars from 1,811 ratings when checked. Accessible positive reviews describe fewer or milder flashes; the reader discussion we read also raises cost and feeling unwell. These are individual experiences, not a measured success or side-effect rate.
That's a positive average on Amazon. But a star rating answers a narrow question: did the people who bothered to leave a rating like it? It can't tell you whether Relizen will work for you, or whether it worked better than doing nothing. Here's what each review pool actually counts.
Where Relizen's ratings come from (checked October 16, 2026)
Swipe or scroll horizontally to view all columns.
| Where | Rating | Number | What was available | What it counts | Useful for | Not useful for |
|---|---|---|---|---|---|---|
| Bonafide's Relizen reviews | Current aggregate not captured | No verified current total | Selected Relizen stories, including entries the seller labels “Verified Buyer” | Customer stories published by the seller; identities and purchases not independently checked by us | Questions about expectations and timelines | A success rate or proof it beats placebo |
| Amazon | 4.0 of 5 | 1,811 ratings | Aggregate rating on a listing with multiple supply options; individual critical-review text was not available to us | Ratings on that listing, not necessarily all verified purchases or all one-month buyers | A second review pool, separate from the seller's selected stories | A treatment effect or a representative survey of every buyer |
| Reddit's r/Menopause | No rating | One discussion read | Reports of nausea, dizziness or jitteriness; other commenters describe benefit and cost | People who chose to post, without verified diagnoses or treatment histories | Questions to bring to a clinician or pharmacist | How often a reaction or benefit happens |
Ratings change. We report Amazon's observed total, not an independently sampled customer survey. Bonafide's aggregate widget was unavailable to us, so we do not assign it a current score or convert selected stories into percentages.
What happy reviewers say
Accessible positive stories describe fewer or milder hot flashes, sometimes after about two months. Bonafide also publishes a Relizen story about night-sweat relief, and a commenter in the Reddit discussion says she received a sample at her yearly exam. We did not count these themes across all reviews.
Julie, whom Bonafide labels a verified buyer, writes: “My hot flashes are less frequent and less intense after about 2 months of taking Relizen.” That's one woman's experience, published on the seller's site. We did not independently verify her purchase or outcome. It isn't a typical-results claim, and it isn't proof.
What unhappy reviewers say
The accessible discussion raises three practical concerns:
- Feeling unwell. The Reddit thread describes nausea, dizziness and a jittery feeling. Another commenter describes dizziness and a racing heart. These reports do not establish that Relizen caused the symptoms.
- The price. A commenter who reports benefit still calls it expensive. Feeling some improvement and deciding whether it is worth the cost are separate questions.
- Not knowing how long to wait. A commenter who received a clinician's sample asks about longer-term experience. The studies' timelines are more useful than a single person's prediction.
And if your own experience is “it did nothing” or “it stopped working,” those are useful things to bring to a clinician. A review or seller reply is not a reason to take a break, restart or increase what you take.
How to read these reviews without being fooled by them
Reviews are great at showing you what to ask. They're bad at telling you what caused a change.
Swipe or scroll horizontally to view all columns.
| What a review says | The useful question it raises | What it can't prove |
|---|---|---|
| "My hot flashes improved" | What else changed at the same time? Hot flashes often ease on their own over time. | That Relizen caused the change |
| "I felt sick on it" | Which symptoms, when, and what else was she taking? | That the reaction is common |
| "It's too expensive" | How much money do you commit before you can judge it? | That a bigger plan is a better deal |
| "It worked fast" or "It took months" | What timeline did the studies use? | When it will work for you |
Three more reasons the stars can't settle it. A seller chooses which stories to feature. Reviewers are self-selected, and we do not know how their experiences compare with those of people who never leave a review. And without a placebo (a look-alike pill without the study's active treatment) for comparison, nobody can separate Relizen's effect from the natural ups and downs of hot flashes or from simply expecting to feel better.
So let's look at the studies.
What is Relizen, and is it really hormone-free?
Relizen is an over-the-counter (OTC) dietary supplement made from a purified Swedish flower pollen extract. Bonafide's directions are two tablets once a day for hot flashes and night sweats. Its listed formula contains no estrogen, progesterone or soy, and it is not an FDA-approved drug. “Nonestrogenic” means no estrogen-like effect in the tests performed—not necessarily no trace of any plant estrogen.
Relizen at a glance (Bonafide's product page, checked October 16, 2026)
Swipe or scroll horizontally to view all columns.
| Fact | Detail |
|---|---|
| What it is | A dietary supplement, not a drug |
| Active blend | "Purified Cytoplasmic Blend": a proprietary Swedish flower pollen extract called Sérélys, made of Pollen + Pistil Extract PI-82 and Pollen Extract GC-FEM. The Supplement Facts label lists 320 mg per two-tablet serving; the amounts of the individual extracts are not disclosed. |
| Other ingredients | Isomalt, maltodextrin, microcrystalline cellulose, acacia, magnesium stearate, vitamin E (as d-α-tocopheryl succinate), hydroxypropyl methylcellulose, silica, polysorbate |
| Directions on the label | Two tablets once a day, with or without food. The one-month bottle has 60 tablets: 30 two-tablet servings. |
| Free of (seller's statement) | Hormones, parabens, soy, gluten, GMOs |
| Related extract names used abroad and in research | Femal, Femalen and Sérélys, according to The Menopause Society; research also uses the name PureCyTonin |
| Who sells it | Bonafide Health, owned by Pharmavite (the maker of Nature Made vitamins) since a $425 million purchase announced in November 2023 |
| Insurance | Bonafide says its products are not covered by traditional insurance. Some buyers may qualify to use health savings account (HSA) or flexible spending account (FSA) funds through a health survey and provider review with Truemed. |
A few terms, in plain words:
- Menopause-related hot flashes and night sweats are what doctors call vasomotor symptoms. Estrogen changes affect the brain's temperature-control system; sweating or flushing can also have other causes.
- "Pollen extract" here is not bee pollen. Bonafide says it uses the inside of the pollen grain and removes the allergy-causing parts. That's the company's claim; the clinical sources we could review do not establish safety for every person with a pollen allergy.
- Hormone-free is true, and it matters. Laboratory research on the extract found tiny, subeffective amounts of some plant estrogens but no estrogenic uterine-growth effect in the animal test. That helps explain interest among women who cannot take estrogen. But hormone-free does not mean proven, and it does not mean risk-free.
Is Relizen FDA-approved?
No. Relizen is sold as a dietary supplement. The FDA does regulate supplements, but differently from medicines: it does not approve supplements for safety or effectiveness before they're sold. Bonafide's page mentions an "FDA-registered" manufacturing facility. Registration means the factory is listed with the FDA. It is not approval of Relizen.
Does Relizen work? What the studies actually show
One small randomized, double-blind trial found that a related pollen-extract preparation helped hot flashes more than a placebo after three months. But when researchers pooled the controlled studies together in 2024, the benefit was no longer statistically significant, and The Menopause Society's 2023 guidance does not recommend pollen extract for hot flashes.
That's the honest summary. Here's how we got there, strongest evidence first.
The research on Relizen's pollen extract for hot flashes
Swipe or scroll horizontally to view all columns.
| Study | What was studied | What it found | What it can't tell you |
|---|---|---|---|
| Winther and colleagues, 2005 (Climacteric) | 64 women in menopause, randomly assigned to pollen extract or a placebo, two tablets daily for three months; 54 finished | 65% on pollen extract reported fewer hot flashes, compared with 38% on placebo. The abstract also reports a separate 27% diary-count comparison with placebo after three months. | One small study. "65% responded" is not "65% fewer hot flashes" (see below). |
| Acquarulo and colleagues, 2024 (Menopause), a review that combined five studies (420 women) | One randomized trial and four observational studies | Before-and-after improvement looked big. But when only the controlled studies were pooled, the results were no longer statistically significant. The authors said improvements in uncontrolled studies may have been a placebo effect; use was not associated with significant adverse effects in the synthesis. | Doesn't prove that nobody benefits. Before-and-after reports cannot establish the treatment effect on their own. We read the original abstract, not the full pooled-analysis methods. |
| Bounous and colleagues, 2024 (Gynecological Endocrinology) | 39 breast cancer survivors randomly assigned to the same extract family or placebo for three months; 30 finished | Hot flashes dropped within the pollen group from start to month three. No sleep improvement in either group; one participant withdrew after leg pain. The study was sponsored by Sérélys Pharma. | The reported significance tests compare each group with its own starting point, not a clear treatment-versus-placebo effect. One group having a significant change and the other not is not itself proof of a difference. The study is too small and short to establish long-term cancer safety. |
| Two single-group studies of 104 and 108 women (summarized by The Menopause Society) | Women took pollen extract with no comparison group | Symptoms improved after about three months | Without a comparison group, time and expectation could explain it |
| De Franciscis and colleagues, 2020 (Current Pharmaceutical Design) | Six-month prospective observational study: 57 women used pollen extract, 60 soy isoflavones and 47 no treatment | Reported greater hot-flash and sleep improvement with pollen than soy at six months | Included an untreated group, but was not a randomized, blinded placebo trial. Group differences can have explanations besides treatment. |
| Capozzi and colleagues, 2026 (Nutrients) | Looked back at 45 women; 22 took pollen extract plus vitamins D and K2 | Reported symptom improvement and better bone markers | A different formula, not Relizen alone. Not proof of stronger bones or fewer fractures. |
| Bonafide's cited customer survey (Bernsley, 2021) | Seller says 4,925 customers had used Relizen for at least three months | Seller reports 75% with fewer hot flashes; 70% with fewer night sweats | No placebo comparison. People who stopped before three months do not meet the stated inclusion rule. Full survey methods were not available to us. |
Why "65% responded" doesn't mean "65% fewer hot flashes"
These are two different kinds of numbers, and mixing them up changes what the study promises.
In the 2005 trial, 65% of women on pollen extract were counted as "responders," meaning their hot flashes went down. On placebo, 38% were responders. The difference is 27 percentage points.
That number tells you how many women improved. It doesn't tell you how much each one improved. If you have ten hot flashes a day, it does not mean you should expect 6.5 fewer. Notice, too, that more than a third of women in the placebo group improved. That's normal in hot-flash research, and it's exactly why a comparison group matters.
What does The Menopause Society recommend?
The Menopause Society (formerly the North American Menopause Society) reviews and grades evidence in its position statements. Its 2023 nonhormone therapy position statement names Relizen, Serelys, Femal and Femalen. It walks through the 2005 trial and two single-group studies. Then it concludes that, based on expert opinion and limited research, pollen extract "is not recommended."
The same statement does recommend several hormone-free options, with the strongest evidence grade (Level I) for cognitive behavioral therapy, clinical hypnosis, certain antidepressants (SSRIs and SNRIs), gabapentin and fezolinetant. It says hormone therapy, also called hormone replacement therapy (HRT), remains the most effective treatment for hot flashes. A newer hormone-free pill, elinzanetant (Lynkuet), was approved by the FDA in October 2025, after that statement came out.
Our read: Relizen isn't proven useless. It also isn't proven enough to replace better-supported care. For mild symptoms and a strong preference for an OTC option, a time-limited try can be a personal choice after reviewing your medicines and history with a clinician or pharmacist. For symptoms that are hurting your sleep, work or mood, it's a weak first bet.
Relizen's marketing claims, checked against their own sources
Several of Relizen's headline numbers come from customer surveys or laboratory sources, not from placebo-controlled menopause trials. We traced the major claims to Bonafide's footnotes and read the underlying text where available, so you can see the evidence type and the gaps.
This isn't an accusation of wrongdoing. A customer survey and a controlled clinical trial answer different questions. The point is to let you weigh each number for what it is.
Relizen claim check (claims as shown October 16, 2026)
Swipe or scroll horizontally to view all columns.
| The claim | Where we saw it | What the cited source actually is | What it means for you |
|---|---|---|---|
| "Backed by three placebo-controlled clinical trials" | Bonafide product page (footnotes 30, 31, 32) | Footnote 30, Winther 2005: a real placebo-controlled menopause hot-flash trial. Footnote 32, Gerhardsen 2008: a placebo-controlled trial in premenstrual syndrome (PMS), not menopause; overall PMS results did not significantly differ, although some sleep and subgroup findings favored the extract. Footnote 31, D'Alterio 2015: we couldn't confirm its design, and The Menopause Society's 2023 review describes only one placebo-controlled trial of this extract for hot flashes. | Of the three cited papers, we verified one as a menopause hot-flash trial, one as a PMS trial and could not verify the third's design. The separate small 2024 cancer-survivor trial is discussed above. |
| "75% of women experienced reduced hot flash frequency" and "70%… reduced night sweats" | Bonafide product page (footnote 36) | A survey of 4,925 customers who had taken Relizen for at least three months | Women who quit early aren't counted. There's no placebo group. These are not trial results. |
| "1 in 2 women experience hot flash relief by month two" and "7 in 10 after 12 weeks" | Bonafide product page (footnote 36) | The same customer survey | Same caution |
| "Shown to significantly reduce hot flash frequency by month two" | Bonafide product page (footnote 37, Elia and Mares, 2008) | We couldn't access this study. It isn't the one placebo-controlled trial The Menopause Society describes. | The cited study's full design and results were not available to us, so we cannot independently verify this precise month-two claim |
| "Sleep quality improved by 67%" and "56% more time in bed sleeping" | Bonafide product page (footnote 38) | De Franciscis 2020: observational comparison of pollen, soy isoflavones and no treatment | Not a randomized placebo trial. Its abstract reports sleep-score changes, but we could not verify the exact metric and calculation behind these two seller percentages. They do not mean 56% more hours of sleep for every user. |
| "No hormonal effect" | Bonafide product page (footnotes 29, 34, 35) | Lab and animal research, a conference poster and an internal company report | Laboratory findings support a nonestrogenic effect in those tests, not blanket safety for every woman. Internal reports were not independently examined. |
| Does the extract interfere with tamoxifen? | The question examined by Goldstein 2015 | A test-tube study showing the extract barely affected CYP2D6, the liver enzyme that activates tamoxifen | A good sign, but a lab finding. Your oncology team should still weigh in. |
| "Used safely by women in Europe for over 20 years" | Bonafide product page | Company data. The same page's FAQ says "over 15 years." | Both are company statements about duration of use. “Over 20 years” also satisfies “over 15 years”; neither establishes long-term safety through a controlled study. |
| Large user and clinician-recommendation counts, including 235,000+ women on the product page | Bonafide page and retailer marketing | Company figures without independently checked methods or denominators | Popular isn't the same as proven |
| "FDA-registered" facility | Bonafide product page | Registration is a factory listing | Not FDA approval of Relizen |
The pattern is worth naming. The product page puts survey numbers ("75% of women") right beside trial language ("clinically tested"), and most readers won't open the footnotes. Now you have.
Whether a supplement is enough for you depends on more than reviews or studies. The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.
It's free, takes about 60 seconds and doesn't ask for your email. Its questions cover symptoms, what you've already tried, age, state and health history. It doesn't diagnose anything or decide whether hormones or any medicine is right for you; a clinician does that. We may earn a commission from the providers it features, and that affects which ones appear. How the tool works.
How long does Relizen take to work?
The main trial assessed daily use over three months, and Bonafide recommends at least three months. That is an assessment timeline, not a guarantee of relief or a reason to keep taking something that makes you feel unwell. Discuss when to review the result rather than treating three months as a required wait for care.
Swipe or scroll horizontally to view all columns.
| Point in a trial | What the evidence or the seller says |
|---|---|
| Day 1 to about week 4 | Bonafide says the effect builds over time. That is the seller's expectation, not a guarantee of what you will feel in the first month. |
| About month 2 | The 2005 abstract reports a 23% decrease in its hot-flash symptom-rating assessment and a significant between-group comparison. Separately, Bonafide attributes a roughly half-of-users relief claim to its customer survey. Those are different measures. |
| Month 3 | The main trial's endpoint. The 2024 review also looked at three-month results. |
| Month 6 | The 2020 study compared pollen extract with soy at six months. |
Two practical points.
First, the clinical studies reviewed used daily dosing. They do not establish that taking Relizen only on bad days works.
Second, compare that timeline with prescription options. The large trials of fezolinetant and elinzanetant measured hot flashes at weeks four and twelve. If you're losing sleep every night, three months of waiting is a real cost, not just a detail.
If you and your clinician decide to try Relizen, use day 60 and day 90 as practical note-taking reminders, or use the review dates your clinician suggests. These are not medical deadlines: 12 weeks is 84 days, and three calendar months is not always 90 days. Our 90-day worksheet keeps the dates separate. Also note any subscription-processing date: cancellation needs to happen earlier, not after the next box is processed.
Relizen side effects, allergies and drug interactions
The 2024 review did not find an association with significant adverse effects, but the studies are too limited to promise no side effects. In reader discussions, some people report nausea, dizziness or feeling jittery. If you have a hormone-sensitive cancer, take tamoxifen or an antidepressant, or have a history of serious allergies, check with your clinician or pharmacist first.
What's been reported
- In the research: The 2024 synthesis found no association with significant adverse effects. In the small cancer-survivor trial, one woman on the extract reported leg pain and withdrew; the study did not establish that the extract caused it. Bonafide also says its studies found side effects similar to placebo, but that seller statement is not a complete safety assessment.
- In reader reports: nausea, dizziness, jitteriness and a racing heart appear in the discussion we read. These are individual reports. They cannot tell you how often a reaction happens or whether Relizen caused it.
Small studies can miss uncommon problems. So "few side effects reported" is not the same as "no side effects."
Does Relizen cause weight gain?
The sources we could review do not establish weight gain as a Relizen side effect, but they cannot rule it out for an individual. Relizen also is not an established weight-loss treatment; results from a different combined supplement formula cannot prove that it helps with weight. If weight is your main concern, see weight care in menopause.
Relizen and breast cancer or tamoxifen
This is where a lot of women find Relizen, often because estrogen isn't an option.
What's encouraging: laboratory work found no estrogenic effect in the tests performed, and a test-tube study found negligible inhibition of an enzyme involved in activating tamoxifen. The small 2024 trial in breast cancer survivors reported generally good tolerability over three months, with one leg-pain withdrawal.
What's missing: long-term safety data in cancer survivors, and a clear result showing it beats placebo in that group.
So bring the label to your oncology team before starting. For contrast, the official label for low-dose paroxetine, an approved hot-flash medicine, warns it may make tamoxifen less effective. That's one reason hot-flash treatment after breast cancer is best chosen with your cancer team, not off a store shelf.
Relizen with antidepressants or other medicines
Some researchers propose an effect on serotonin, a brain signaling chemical involved in temperature control, based partly on laboratory work. That does not establish either a clinical antidepressant-like effect or a proven interaction with antidepressants. If you take an antidepressant, migraine medicine or other prescription, ask your pharmacist to review the actual label with your full medicine list. “Hormone-free” does not mean “interaction-free.”
Pollen allergy
Bonafide says its purification removes allergens. The clinical material we could read does not establish safety for every person with a pollen allergy. If you have a pollen allergy or have ever had a serious allergic reaction, ask a clinician about the exact product first.
Get help right away if you have trouble breathing, swelling of your lips, tongue or throat, or feel faint after taking any supplement. Call 911. A severe allergic reaction is an emergency, and nothing on this page, including our quiz, is the right next step.
Get checked, whatever you decide to take, if you have bleeding after menopause, night sweats with fever or unexplained weight loss, or symptoms of early or premature menopause. A new or persistent racing heart also deserves clinical review. Sweating and flushing can have causes other than menopause; a clinician can decide what examination or testing is needed.
How much does Relizen cost? Money due now vs. a three-month try
Buying 90 days of Relizen through Bonafide costs $114 to $189 before tax with the three-month, monthly or separate single-box options. The six-month plan requires $198 up front, with extra supply left. Subscriptions work out to $33 to $42 per 30-day supply, but opened boxes are not returnable under the standard policy.
The number on the product page and the money that leaves your account aren't always the same. Here's the full picture.
Relizen cost by purchase option (Bonafide and Amazon, checked October 16, 2026)
Swipe or scroll horizontally to view all columns.
| How you buy | Listed payment now, before tax | Cost per 30-day supply | Cash committed to buy at least 90 days of tablets | Price of 360 days of tablets | Later payment terms |
|---|---|---|---|---|---|
| Monthly subscription | $42 | $42 | $126 across three charges | $504 across twelve charges | Listed as paid monthly; standard shipping included; confirm processing/charge dates |
| 3-month plan | $114 | $38 | $114 in one charge | $456 across four charges | Listed as paid quarterly; standard shipping included |
| 6-month plan | $198 | $33 | $198 paid, with 90 days of supply left after using 90 | $396 across two charges | Listed as paid semiannually; standard shipping included |
| Single box, Bonafide | $58 + $5 standard shipping = $63 | $63 with one box shipped separately | $189 for three separate single-box orders | $756 for twelve separate single-box orders | No automatic renewal; combined-order shipping could change the total |
| One-month box, Amazon | $62, plus any shipping | $62, plus any shipping | $186, plus any shipping | $744, plus any shipping | One-time listing price, not a subscription discount; Amazon's terms apply |
The one-month bottle has 60 tablets, or 30 days at the seller's directions. Twelve such supply months are 360 days, not a 365-day year. These are purchase/supply comparisons, not a promise that the same charges will fall inside every reader's first 90 calendar days of use. Sales tax, optional add-ons and expedited shipping are excluded; Amazon shipping is unknown. Any total including an unknown required charge is incomplete.
What the math shows:
- The 3-month plan is the cleanest prepaid fit for a planned 90-day supply. It is one charge of $114, $12 less than three monthly charges. That is a buying comparison, not an instruction to take Relizen for 90 days. Check the next processing date before you subscribe.
- The 6-month plan has the lowest monthly price, but it's a bigger bet. It costs $84 more up front than the 3-month plan, before you know whether Relizen works for you. A lower price per tablet doesn't make it more likely to help.
- A 30-day cycle is not a calendar month. If your confirmed schedule charges on purchase day and every 30 days afterward, 13 charges fall in the first 365 days: $546 at $42 each. That last charge buys supply extending beyond the year. Do not assume this cadence from the word “monthly”; check your order and account.
- Ongoing use adds up. The listed options cost $396 to $756 for 360 days of tablets, before tax and any unlisted charges. Cash paid within a calendar year can be higher when the next prepaid shipment is charged before year-end.
Can you get your money back if Relizen doesn't help?
Not after you've opened it. Bonafide's published terms accept returns only for unopened, sealed products:
- First orders: within 30 days of the shipment date (not the day it arrives)
- Refills: within 14 days of the shipment date
- A $7 return-shipping fee is taken out of the refund
- Bought on Amazon or in a store? That seller's return rules apply instead
So the standard policy is not a “try it for three months and get a refund” offer. Canceling future shipments and getting money back for a box you have already opened are two different things. Opening a box makes it ineligible for a standard unused-product return.
The cancellation detail that matters: Bonafide's terms require cancellation at least five business days before your next processing date. Check that date in your account and cancel through the account or contact support as instructed. “Cancel anytime” does not mean you can wait until the next shipment is being processed and avoid the charge. Get confirmation, and contact support early about a return; the policy's shipment-based window is not a promise that a request on the final day will qualify.
Promotions, HSA and FSA
- The “save 34%” comparison is the listed $38 monthly equivalent versus a $58 one-time bottle price: ($58 − $38) ÷ $58 ≈ 34.5%, rounded to 34% in the offer. It excludes shipping. This is the listed subscription-price comparison, not a time-limited coupon verified by us.
- HSA and FSA: Bonafide says some buyers can use these accounts after completing a health survey through Truemed and receiving a letter from a licensed provider. That isn't insurance coverage, and not every purchase will qualify.
For comparison: what clinician-led care costs
If you're weighing Relizen against seeing a clinician for prescription treatment, Gala Health advertises menopause care from $69 a month, which it says includes provider care, the prescription and shipping, with no insurance billing. Its dedicated HRT landing page advertises $69 monthly at a flat rate.
Three $69 charges would be $207, or $93 more than Relizen's $114 three-month plan. That is a subscription-price illustration, not a complete first-90-day care quote: confirm the billing dates, exact included medicine or combination, any required laboratory charges and all other fees before comparing totals. Our Gala Health HRT review has the detailed price and terms comparison.
Copy this before you buy:
MY RELIZEN COST CHECK (keep this private)
Where I'm buying: Bonafide / Amazon / store
Plan: single box / monthly / 3-month / 6-month
First order/charge date: __________
Charged today: $______ Tax/shipping included? __________
Tablets in what I bought: ______ (at the label's 2 a day = ______ days)
Actual first-use date: __________
Next PROCESSING date: __________ Next charge date: __________
Next amount charged: $______
Cancellation deadline confirmed with seller: __________
Bonafide: at least 5 BUSINESS days before the next PROCESSING date.
Do not wait for the day-90 symptom check to manage renewal.
Ship date of first order: __________
Stated unopened-return window ends: __________ (shipment + 30 days)
Refills: shipment + 14 days. Contact support early about return timing.
$7 return-shipping fee; no standard return of opened products.
Day 60 of use: __________ (first-use date + 59 days)
Day 90 of use: __________ (first-use date + 89 days)
Cash charged in first 90 days after first charge: $______
Cash charged through day 90 of actual use: $______
Supply already paid for but not yet used: ______ days
Questions / review date agreed with clinician: __________
Should you try Relizen? Who it fits and who should skip it
Relizen is most relevant to discuss when hot flashes are mild to moderate, you prefer an OTC option and you accept uncertain benefit after a medicine and health-history review. It is a poor first fit if symptoms are severe, you need help soon, or daily use over about three months has not brought enough relief.
Find your situation below. This is a way to sort your options, not a medical screening.
Swipe or scroll horizontally to view all columns.
| Your situation | Is Relizen a fit? | Why | A useful next step |
|---|---|---|---|
| Mild to moderate hot flashes, prefer an OTC option, accept uncertainty | A personal option to discuss | Limited evidence; medicines and history still matter | Compare the payment plans and use the worksheet. Set a clinical review date and a separate, earlier subscription decision date. |
| Severe hot flashes, losing sleep, missing work | Not first | Better-supported options exist; you do not have to wait months to seek care | A clinician visit: see when to see a clinician |
| History of breast cancer, or taking tamoxifen | Ask your oncology team first | Lab results and one small trial are encouraging; long-term data are missing | Your cancer team, who can also discuss prescription options |
| Told to avoid estrogen because of blood clots or stroke | Possibly, with your doctor's okay | It's not estrogen-like in lab tests | Ask about FDA-approved hormone-free medicines too |
| Taking an antidepressant or other prescription medicine | Check with your pharmacist first | Clinical interaction evidence is limited; a proposed laboratory mechanism is not proof of an interaction | A pharmacist review of the exact products |
| Already took it every day for three months, not enough relief | Time for a different approach | You gave it the timeline the research used | See what to do if it didn't work |
| Took it for years and hot flashes came back | Get checked | Symptoms can change, and other causes are possible | A clinician visit; bring your notes |
| Main problem is vaginal dryness or painful sex | Not a proven treatment for this | Some studies assessed vaginal symptoms, but they do not establish a dependable treatment benefit | Vaginal estrogen and other local treatments |
| Main problem is mood, brain fog or weight | Not a proven treatment for this | Some studies assessed broader symptoms; that does not establish treatment for these concerns | Mood or weight care |
| Under 40, or periods stopped early | Not first | Early symptoms need an evaluation | An in-person clinician |
A 30-second self-check
Answer these on paper or in your head; there is nothing to submit here.
- Are my hot flashes manageable enough that I am comfortable discussing an option with uncertain benefit, rather than needing care now?
- Have I reviewed the label, my medicines and any relevant medical history with a clinician or pharmacist?
- Am I comfortable with the actual upfront payment and return rules—$114 for the three-month plan, $126 across three monthly charges, $189 for three separately shipped one-time bottles, or $198 up front for six months, before tax?
Three yeses? You have addressed the main practical reasons to consider a time-limited try—not proved that Relizen is medically right for you. Buy only the supply you intend, use the review dates agreed with your clinician, and note the cancellation cutoff before choosing auto-renewal. The worksheet below helps keep those decisions separate.
This link goes straight to Bonafide. We don't earn anything from it.
Any no? That's useful information, and it's completely fine. Keep reading: the next sections cover options with stronger evidence, including ones without hormones.
Relizen vs. Thermella and prescription options: what works better?
Relizen and Thermella are different hormone-free supplements from Bonafide; the sources reviewed here do not establish which works better. Hormone therapy is the most effective treatment for hot flashes, while FDA-approved hormone-free medicines such as fezolinetant, elinzanetant and low-dose paroxetine offer other routes when hormones are not right or not wanted.
Going hormone-free doesn't limit you to supplements. Here's how the main routes compare.
Hot flash options compared (checked October 16, 2026)
Swipe or scroll horizontally to view all columns.
| Relizen | Thermella | FDA-approved hormone-free medicines | Hormone therapy | |
|---|---|---|---|---|
| What it is | Pollen-extract supplement | Supplement: Longvida curcumin 600 mg, decaffeinated green tea extract 150 mg, spirulina extract 85 mg per two tablets | Prescription pills approved for moderate to severe hot flashes: fezolinetant (Veozah), elinzanetant (Lynkuet), paroxetine 7.5 mg (Brisdelle) | Systemic (whole-body) prescription estrogen, usually with a progestogen—progesterone or a related medicine—to protect the uterine lining if you have a uterus |
| FDA status | Supplement, not approved as a treatment | Supplement, not approved as a treatment | FDA-approved for hot flashes | FDA-approved products exist; compounded versions are not FDA-approved |
| Strength of evidence | One small menopause trial plus a small cancer-survivor trial; the 2024 controlled synthesis was not significant; TMS 2023: not recommended | Seller cites clinical reports and data on file, including placebo-controlled research; full reports not independently appraised here | Drug-specific randomized trials; fezolinetant and certain SSRIs/SNRIs carry TMS 2023's top evidence grade; Lynkuet was approved later | The most effective treatment for hot flashes, per The Menopause Society |
| Timing evidence, not a promise | Studies assessed daily use over months; the older trial reported changes by month two | Seller claims as early as two weeks; not a head-to-head result against Relizen | Trials assessed benefits at weeks 4 and 12; individual response varies | Often within weeks; timing depends on the person and prescribed treatment |
| Main cautions | Limited data in some groups | Ask a pharmacist about interactions | Fezolinetant: boxed warning for rare serious liver injury, with liver blood tests before starting, monthly for three months, then at months 6 and 9. Elinzanetant: label (revised August 2026) warns about daytime sleepiness/impairment, liver enzyme rises, pregnancy loss and seizure risk; liver tests are needed before treatment and at three months. Paroxetine: may reduce tamoxifen's effect. These are key cautions, not the complete prescribing information. | Systemic HRT is generally not advised with certain cancers, past blood clots, stroke, active liver disease or unexplained bleeding. Individual history, timing and route matter; local vaginal treatment is a different decision. |
| Cash cost | $33–$63 per 30-day supply; prepaid plans require more up front | $35–$45 per month-equivalent on subscriptions; $60 + $5 shipping for a one-time month; prepaid plans require more up front | Varies by medicine, pharmacy and insurance | Varies; some online services bundle it into one monthly price |
| Is a prescription required to buy it? | No; a safety discussion may still be needed | No; a safety discussion may still be needed | Yes | Yes |
Which is better, Relizen or Thermella? They are different products with different ingredients. Thermella's faster-start claim is not evidence that it beats Relizen in a head-to-head comparison. Relizen's extract has the older published placebo-controlled menopause trial; The Menopause Society's 2023 statement specifically advises against pollen extract, but does not establish a product-specific assessment of the current Thermella offer. Discuss the exact products with a pharmacist before combining them.
Non-drug options with strong evidence. Cognitive behavioral therapy (CBT) and clinical hypnosis carry The Menopause Society's top evidence grade. CBT can reduce how disruptive or distressing flashes feel; clinical hypnosis has also reduced hot-flash frequency and severity in trials. A clinician can help you find a trained practitioner and consider these alongside other care.
A few honest notes on the prescription column:
- Some prescription choices are off-label. Other antidepressants (like escitalopram or venlafaxine), gabapentin and oxybutynin are used for hot flashes even though they weren't approved for that use. That can be perfectly reasonable, but ask why a clinician picked a specific one.
- Hormone therapy isn't an automatic next step after a supplement. It's a choice to make with a clinician who knows your history. If you have a uterus, systemic estrogen usually needs a progestogen or another specifically approved uterine-protection approach. Low-dose local vaginal estrogen is a different treatment decision and does not treat hot flashes.
- "Bioidentical" isn't an approval status. Ask for the exact product name and whether it's an FDA-approved product or a compounded one. Our compounded vs. FDA-approved guide explains why that matters.
Want to stay hormone-free but look beyond supplements? Our guide to non-hormonal options for menopause walks through each approved and off-label medicine in plain English, including low-dose paroxetine online and oxybutynin vs. Veozah. And if you're curious about other supplements, how plant estrogens differ from a nonestrogenic pollen extract.
When does seeing a clinician make more sense than another supplement?
A clinician visit makes more sense when the question is no longer "which supplement should I buy?" but "which treatment fits my symptoms and my history?" That's often the case when hot flashes are severe, when a supplement hasn't helped after three months, or when you want an FDA-approved option with or without hormones.
You can see your own doctor, a gynecologist or an online menopause service. The right one depends on your insurance, your history and the kind of follow-up you want.
When Gala Health is a good fit
Gala Health is an online menopause service. It's most relevant here if you want a licensed clinician to look at prescription options, you're comfortable paying cash instead of using insurance, and you're ready to move past trying another bottle.
What Gala offers (Gala's own statements, read October 16, 2026):
- Hormone-free and hormone options in one place. Its non-hormonal page lists "FDA-approved non-hormonal options," naming fezolinetant. Its hormone-health page lists estradiol pills and patches, progesterone and vaginal estradiol. A clinician chooses, and a prescription isn't guaranteed.
- A published starting price, with a flat-price HRT offer. Gala's main hormone-health page says from $69/month; its dedicated HRT page advertises $69/month flat, including provider care, prescription medication and shipping. Those are advertised terms, not a quote for every medicine or combination. Gala says it does not bill insurance and accepts HSA/FSA cards.
- Ongoing support. Gala says provider messaging, symptom check-ins and dose adjustments are included for as long as you're treated.
- A hormone-free care route is listed. Gala's non-hormonal page includes options for women who do not want hormones or cannot take them. That does not establish suitability for an individual cancer history; start with your oncology team when cancer treatment is involved, and confirm any new provider can coordinate care.
Allison, 51, whom Gala presents as a patient, is quoted on its hormone-health page saying, “Gala’s provider walked me through the options.” That is a testimonial Gala chose to publish; we did not independently verify her care. Read it as a service anecdote, not proof of a medical result.
What to know before you pay. Gala lists medication types and says it offers FDA-approved forms, but the disclaimer on another HRT landing page discusses compounded drugs, which are not FDA-approved. We did not independently verify the exact finished product a reader would receive. Ask for its name, manufacturer and approval status; “bioidentical” alone does not settle that. We also could not confirm whether every non-hormonal prescription is included in $69, or who pays for required liver tests if fezolinetant is prescribed. Its non-hormonal page also includes HRT/progesterone wording, so ask for a drug-specific plan rather than relying on that page's general promises.
The refund policy linked from Gala's HRT offer requires cancellation at least 72 hours before the next billing date. It also says billing begins at intake completion, while some HRT messaging ties charges to approval, and the policy contains weight-loss wording and differing statements about disqualification refunds. Confirm the terms for your actual HRT order: which exact medicine, its complete cost, when the first charge happens, what is refunded if you are not approved, and the renewal/cancellation deadline. Gala's landing page says no contract or membership, but that does not mean a processed payment is refundable. Our full Gala Health HRT review has more detail.
Before changing providers, also ask who handles refills, follow-up and records during the move. We did not verify a guaranteed bridge prescription or continuing access after a paid care period ends.
If those answers work for you, Gala offers a direct online route to a clinician's review of prescription options, with ongoing messaging afterward. Some states require a video visit. Availability, timing and the prescription itself depend on the provider's review and your state.
Gala may pay The HRT Index if you enroll. A prescription is never guaranteed; a licensed clinician decides what's right for you.
When insurance or your own doctor is the better route
A low cash price isn't automatically the best price. If you have good insurance, a covered visit and a covered generic at your pharmacy can cost less. And a clinician who already knows your history can be worth more than a new subscription.
Swipe or scroll horizontally to view all columns.
| Care route | Best when | What we verified | Ask before you book |
|---|---|---|---|
| Gala Health | You want cash-pay online care and ongoing messaging | Main page says from $69/month; dedicated HRT offer says $69/month flat with provider care, medication and shipping; no insurance billing (provider statements, October 16, 2026) | Exact medicine/combination and approval status; complete quote including labs; first and renewal charge dates; refund/cancel terms; state and clinical age limits; refill continuity |
| Midi Health | You want to check insurance and have scheduled video visits | Provider says it accepts many major plans; self-pay visits listed at $250 for the first and $150 for follow-ups (checked October 16, 2026) | Your exact plan/state, deductible and copay; medication and lab costs; follow-up frequency |
| Your own primary care doctor or gynecologist | You need an exam, have a complex history or value continuity | Depends on your practice and coverage | Appointment wait, expected cost, who handles follow-up |
| Your oncology team | You have a history of breast or other hormone-sensitive cancer | Not applicable | Which hot-flash treatments fit your cancer treatment |
If insurance comes first for you, check your coverage before anything else. Midi's page says it is not in-network with Medicare, although Medicare beneficiaries can use its self-pay route; it says it cannot currently see Medicaid or Medi-Cal patients. An existing covered clinician may be the better route.
We don't earn anything from this link.
To find menopause care near you and check the Menopause Society Certified Practitioner (MSCP) credential, The Menopause Society provides a practitioner search. For a wider look at online services, see our comparison of online HRT providers and what HRT costs in 2026.
What if Relizen didn't work (or you feel worse)?
If you took Relizen daily for about three months and your hot flashes still bother you, your experience is worth discussing with a clinician. That is not a failure on your part. You do not owe an ineffective purchase more months of spending before asking about better-supported options. If you feel unwell, get medical advice rather than pushing through.
If nothing changed. You have three good directions to discuss. A clinician can decide whether any combination makes sense:
- Hormone therapy, if your history allows it. For women without reasons to avoid it, The Menopause Society says its benefits generally outweigh its risks for bothersome hot flashes when started within 10 years of menopause or before age 60. See how HRT helps hot flashes and HRT benefits and risks.
- An FDA-approved hormone-free medicine, like fezolinetant, elinzanetant or low-dose paroxetine. See non-hormonal options.
- CBT or clinical hypnosis, which have strong evidence and do not require taking another medicine.
If it worked for a while, then stopped. Symptoms change over time, and other things can cause hot flashes too. Before you stop, restart or double up on anything, have a clinician take a look.
If you feel worse. New symptoms after starting any supplement deserve a call to your clinician or pharmacist. Don't wait it out because a website said to give it three months, including this one.
Not sure how to bring it up? Copy and paste this into a patient portal message or bring it to your visit:
"I've been taking Relizen (a pollen-extract supplement) for [how long]. My main symptom went from [before] to [now]. I've also noticed [anything new]. What should we review, and are there better-supported options for my situation?"
Ready for a clinician to look at prescription options? If you've given Relizen a fair try and you're comfortable with cash-pay online care, Gala reviews your answers online and lists both hormone-free medicines and HRT.
Gala may pay us if you enroll. A clinician decides what's right for you.
Not sure online care fits your history? Find My HRT Path asks about your symptoms, what you've tried, your age, your state and your health history. It offers care-navigation guidance, including situations where an in-person clinician is the better starting point—not medical clearance for everyone else.
Your Relizen 90-day check: a worksheet you can print
Write down what you remember about your symptoms before use, then jot down the same measures each week. The 90-day sheet is a note-taking aid, not a required treatment period. Comparing your own numbers beats guessing, and it gives a clinician something real to look at.
You don't need to delay care to fill this in. If your symptoms are severe, see a clinician now and bring whatever notes you have.
Relizen 90-day worksheet
Swipe or scroll horizontally to view all columns.
| Record | Date | Hot flashes per day (average over past 7 days) | Nights woken by sweats in past 7 nights (0–7) | How much they bother me (0–10) | Notes: unwanted symptoms, medicines, stress, illness |
|---|---|---|---|---|---|
| Before I start, if available | |||||
| Week 1 — day 7 | |||||
| Week 2 — day 14 | |||||
| Week 3 — day 21 | |||||
| Week 4 — day 28 | |||||
| Week 5 — day 35 | |||||
| Week 6 — day 42 | |||||
| Week 7 — day 49 | |||||
| Week 8 — day 56 | |||||
| Separate day-60 check-in | |||||
| Week 9 — day 63 | |||||
| Week 10 — day 70 | |||||
| Week 11 — day 77 | |||||
| Week 12 — day 84 | |||||
| Separate day-90 check-in |
Day 1 is your first actual day of use. Week 8 is not day 60, and week 12 is not day 90. The separate check-ins also ask about the preceding seven days, so their windows overlap weekly entries; do not add those records together. The 0–10 bother rating is your own description, not a diagnostic or validated success score.
Fill these in once:
- What "better" would mean for me: (for example: sleeping through most nights, or not having to leave meetings)
- Money and renewal: Paid so far $_ · Next processing date · Next charge date · Cancellation deadline confirmed with the seller · Stated unopened-return window ___
- Questions for my clinician or pharmacist: ______
A worked example (made-up numbers to show the math, not a real patient):
Say your first charge is November 1, 2026, and your confirmed order uses an every-30-days billing interval at $42. The first three charges are November 1, December 1 and December 31: $126 during the first 90 days after the first charge, through January 29, 2027. This example excludes tax and assumes included standard shipping.
Now separate the symptom calendar. Suppose the first order ships November 2 and you actually begin using it November 5. Counting that as day 1, day 60 is January 3, 2027, and day 90 is February 2, 2027. A fourth automatic charge would fall on January 30, so cash charged through day 90 of use would be $168, not $126, with an additional 30-day supply paid for. You must manage renewal before the seller's processing cutoff—not wait for the day-90 symptom check.
The first order's stated 30-day unopened-return window would end December 2, calculated from its November 2 shipment. Contact support early to confirm return requirements; that calculated date is not a promise that a last-day return request will be accepted.
Before starting, you averaged 8 hot flashes a day. In week 12 you average 5. That's 3 fewer, or 37.5% fewer, in your own log. Whether that's "enough" is your call. If nights are still a mess, it's still worth a clinician conversation. And remember: the log can't prove Relizen caused the change.
How we reviewed Relizen
We read Relizen's product page, label, purchase terms and accessible customer stories on October 16, 2026. We checked medical claims against The Menopause Society, current FDA labeling and accessible original research, identifying abstract-only and unavailable sources where they matter. We did not take Relizen, and we do not give it a score. This is a documentation and evidence review.
We use The HRT Index Verification Standard. Its five pillars were built for comparing care providers, so for a supplement we apply them to the questions that still matter: is it legitimate, what support comes with it, who it fits, what it really costs and how you get it.
Swipe or scroll horizontally to view all columns.
| Pillar | What we looked for | What we found for Relizen | Status |
|---|---|---|---|
| 1. Clinical legitimacy | The quality of the evidence and the product's regulatory status | A small menopause trial and later small cancer-survivor trial; a 2024 synthesis did not find significant controlled pooled benefits; TMS 2023 says pollen extract is not recommended; supplement, not FDA-approved | Primary guidance and original study abstracts/full text, with the access limits stated above |
| 2. Care quality | Whether a clinician is involved, and what support comes with it | No prescription or clinician visit is required to buy it. Bonafide lists customer-support channels; buying a supplement is not ongoing medical care. | Support listed; not tested by us |
| 3. Medication fit | Symptom relevance and known interaction evidence | Nonestrogenic laboratory findings; limited clinical interaction data; no established treatment role for vaginal dryness, mood disorders or weight loss | Evidence review plus editorial judgment; not individual medical clearance |
| 4. Price transparency | Supply price, payment terms, cancellation and refunds | 60 tablets/30-day bottle; public plan prices; unopened-product returns with a $7 fee; cancellation at least five business days before processing | Primary product/label/terms checked; exact selected account schedule and tax not tested |
| 5. Access | Where to buy, insurance, HSA/FSA | Bonafide and retailer options; Bonafide says traditional insurance does not cover its products; qualifying HSA/FSA pathway through Truemed | Seller/listing information reviewed; individual coverage and qualification not tested |
What would change our view:
- A larger, independent placebo-controlled trial in women with menopause hot flashes
- Updated guidance from The Menopause Society
- Changes to Relizen's price, plans or return policy
- New safety reports
Our full approach is in our methodology. We earn nothing from Relizen. We may earn a commission from Gala Health, which appears on this page as an alternative for readers who need prescription care. How we make money.
Relizen questions women ask before buying
The practical answer depends on whether you still need a product fact, a cost check or a care decision. These final questions fill those gaps without turning a supplement review into a treatment plan.
Is Relizen FDA-approved? No. It's sold as a dietary supplement. The FDA regulates supplements differently from medicines and doesn't approve them for safety or effectiveness before they're sold.
Does Relizen contain estrogen, progesterone or soy? No. Neither hormone nor soy is in its listed formula, and lab tests found no estrogen-like activity. That makes it different from hormone therapy, but it doesn't settle whether it will work or is right for you.
Can I take Relizen only when I have a hot flash? The studies reviewed used daily dosing over months. They do not establish that taking it only during a hot flash works.
Is Relizen the same as bee pollen or other pollen supplements? No. The research involves particular purified preparations, including ones sold as Femal or Sérélys. Another pollen product does not automatically inherit those results; the finished formulation matters.
Is it safe to take Relizen for years? The studies we reviewed lasted three to six months, so they can't show long-term safety for everyone. If you take it long term, review whether it's still helping, along with your symptoms, medicines and cost, with a clinician from time to time.
Can I take Relizen with hormone therapy or another supplement? This page can't approve a combination for you. Ask a clinician or pharmacist to check the exact products together.
Where's the cheapest place to buy Relizen? Among the listed standard options compared here, Bonafide's six-month plan has the lowest 30-day supply price at $33, but it charges $198 up front. The three-month plan is $38 per 30-day supply and $114 up front. Amazon's one-time one-month box was $62 on October 16, 2026. Promotions, shipping and tax can change the delivered price; the lowest unit price is not the lowest payment today.
Does insurance, an HSA or an FSA cover Relizen? Bonafide says its products are not covered by traditional insurance. Some buyers may qualify to use HSA/FSA funds after a Truemed health survey and provider review, with a Letter of Medical Necessity if approved. Check the applicable account rules; this is not the same as insurance coverage.
Does Relizen help with weight loss or bone health? No study we reviewed shows Relizen helps with weight. A 2026 study combined pollen extract with vitamins D and K2 and looked at bone markers, but that's a different formula, and it didn't measure fractures.
Do I have to leave my doctor to try something else? No. The worksheet above can make your next visit with your own doctor more useful. An online service is just one possible route.
The bottom line on Relizen reviews
Relizen is a hormone-free supplement with some encouraging customer stories and a thin layer of clinical evidence. A time-limited try can be a personal choice for manageable symptoms after a safety discussion, not a proven low-risk fix. If symptoms are severe or relief has been inadequate, a conversation about better-supported care is the smarter next step.
Here's the whole page in four lines:
- The reviews: positive seller-published stories, mixed reader experiences, and 4.0 stars from 1,811 ratings on the Amazon listing when checked. Reviews cannot show cause and effect.
- The evidence: one small trial helped; pooled controlled studies didn't show a significant benefit; The Menopause Society doesn't recommend pollen extract.
- The cost: $114 to $189 for 90 days of supply through the three-month, monthly or separately shipped one-time Bonafide options, before tax; the six-month plan charges $198 up front. Opened boxes are not returnable under the standard policy.
- The fit: mild symptoms, patience and a wish to avoid hormones. Not a substitute for care when hot flashes are taking over your life.
Still not sure whether a supplement, a hormone-free prescription or HRT fits you? The free Find My HRT Path quiz asks about your symptoms, what you've already tried, your age, your state and your health history. Then it shows a featured care option, or tells you when to start with an in-person clinician instead. It isn't a medical test, and it doesn't decide your treatment.
And if you already have a doctor who knows your history, it's always fair to bring this page, and your worksheet, to them first.
Sources
Relizen, Bonafide and reader experiences (checked October 16, 2026)
- Bonafide — Relizen product page: listed prices, payment-plan wording, ingredients, directions and cited references
- Bonafide — Relizen Supplement Facts image: visually checked, 320 mg total blend per two-tablet serving; 30 servings per container
- Bonafide — Selected hot-flash reviews: Relizen stories only; do not transfer Thermella stories to Relizen
- Bonafide — Return policy
- Reddit — Relizen discussion: reader language and individual experiences, not medical evidence
- Bonafide — Terms and conditions: subscription processing/cancellation and return terms
- Bonafide — Thermella product page
- Amazon — Bonafide Relizen, one-month supply
- Pharmavite — Acquisition of Bonafide Health, November 30, 2023
Clinical guidance and regulation
- The Menopause Society — 2023 Nonhormone Therapy Position Statement, Menopause 2023;30(6):573–590
- The Menopause Society — Hot Flashes, updated June 2025
- The Menopause Society — Hormone Therapy
- FDA — Questions and Answers on Dietary Supplements
- DailyMed — Veozah (fezolinetant) prescribing information
- DailyMed — Lynkuet (elinzanetant) prescribing information, revised August 2026
- DailyMed — Brisdelle (paroxetine) prescribing information
- FDA — Compounding and FDA: Questions and Answers
- NHS — Anaphylaxis, postmenopausal bleeding, night sweats and early or premature menopause: symptom-review guidance; emergency number in this article is localized to the U.S.
- FDA — Drug Trials Snapshot: Lynkuet: approval October 24, 2025
Research
We read the original abstracts unless a full-text source is identified below. References that Bonafide cites but whose full methods we could not access are identified in the claim-check table; that access limit does not prove those studies are invalid.
- Winther K, et al. Femal, a herbal remedy made from pollen extracts, reduces hot flushes… Climacteric. 2005
- Acquarulo EL, et al. The efficacy of purified pollen extract for reducing vasomotor symptoms in women: a systematic review and meta-analysis. Menopause. 2024
- Bounous VE, et al. A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific cytoplasmic pollen extract for hot flashes in breast cancer survivors. Gynecological Endocrinology. 2024. Publisher-provided full text read on ResearchGate.
- Gerhardsen G, et al. The efficacy of Femal in women with premenstrual syndrome. Advances in Therapy. 2008: publisher abstract.
- Goldstein SR, et al. Does purified Swedish pollen extract… inhibit the CYP2D6 enzyme system? Menopause. 2015
- De Franciscis P, et al. Non-hormonal treatments for menopausal symptoms and sleep disturbances: a comparison between purified pollen extracts and soy isoflavones. Current Pharmaceutical Design. 2020
- Capozzi A, et al. Beneficial effects of purified cytoplasm of pollen associated with vitamin D and vitamin K2 on menopausal symptoms and bone health. Nutrients. 2026. Original-paper abstract read via ResearchGate.
- Hellström AC, Muntzing J. The pollen extract Femal—a nonestrogenic alternative to hormone therapy in women with menopausal symptoms. Menopause. 2012: original abstract; laboratory and animal evidence.
- Appel K, et al. Purified and specific cytoplasmic pollen extract, PureCyTonin, inhibits serotonin reuptake in the rat brain model. 2020: original abstract; laboratory evidence, not a clinical interaction trial.
- Fait T, et al. Prospective observational study of Sérélys in menopausal symptoms. 2019: original abstract; broader symptoms assessed without a comparison group.
Care options (read October 16, 2026, unless noted)
- Gala Health — Hormone health
- Gala Health — Non-hormonal options
- Gala — Dedicated HRT offer, linked terms and linked refund policy: read separately from GLP-1 offer pricing and outcomes
- Midi Health — Pricing and insurance, checked October 16, 2026
- The Menopause Society — Find a menopause practitioner
The HRT Index is an independent editorial publication. We are not a healthcare provider, pharmacy or telehealth service. Nothing here is medical advice, a diagnosis or a treatment plan. For decisions about starting, stopping or combining treatments, talk with a licensed clinician who knows your history. In an emergency, call 911.
Keep reading: